Lamivudine And Zidovudine Tablet
Product Images NDC 33342-003

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 33342-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12x10s (Lamizido 12x10s)

Packaging label for Lamivudine and Zidovudine Tablets USP, 150 mg/300 mg strength, oral tablet form. The label shows the product name and strength prominently highlighted in green. It indicates a package size of 120 tablets (12 x 10 unit-dose) and is labeled for prescription use only. The manufacturer is Macleods Pharmaceuticals Limited, with Macleods Pharma USA listed as the labeler. Storage conditions and usual dosage information references are also visible on the label.*

FDA Label Image

Lami (Lamizido 60s Container)

Label for Lamivudine and Zidovudine Tablets, USP 150 mg/300 mg, film-coated oral tablets. The label includes the NDC 33342-003-09 and states a package size of 60 tablets. It is manufactured for Macleods Pharma USA, Inc. and by Macleods Pharmaceuticals Ltd. Daman, India. Temperature storage instructions and dosage reference are also printed.*

FDA Label Image

6x10s (Lamizido 6x10s)

Packaging label for Lamivudine and Zidovudine Tablets, USP, 150 mg/300 mg, by Macleods Pharmaceuticals Limited. The label indicates an oral tablet dosage form with a package containing 60 tablets (6 x 10 unit-dose). The label includes manufacturer and distributor information, a barcode, and storage instructions.*

FDA Label Image

Lami (Lamizido Lamivudine)

Chemical structure of the active ingredient Lamivudine, showing the molecular arrangement including nitrogen, oxygen, sulfur atoms, and associated bonds in a dihydrothiazine ring and cytosine base.*

FDA Label Image

Zido (Lamizido Zidovudine)

Chemical structure diagram depicting the molecular structure of the active ingredient Lamivudine, showing atoms and bonds including a notable azide group (N3) and a carbonyl group (C=O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.